SYSTEMATIC REVIEW
Published on 07 Jul 2022
A Network Meta-Analysis of the Dose–Response Effects of Dapagliflozin on Efficacy and Safety in Adults With Type 1 Diabetes
doi 10.3389/fendo.2022.923376
- 3,281 views
- 3 citations
- Frontiers in Endocrinology
- Cardiovascular Endocrinology
- Research Topics
- Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes, Heart Failure, and Cardiometabolic Treatment
Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes, Heart Failure, and Cardiometabolic Treatment
12k
Total Downloads
33k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 30 May 2022
Case Report: High-Calorie Glucose Infusion and Tight Glycemic Control in Ameliorating Refractory Acidosis of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis
doi 10.3389/fendo.2022.867647
- 1,787 views
- 2 citations
ORIGINAL RESEARCH
Published on 07 Mar 2022
Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review
doi 10.3389/fendo.2022.836365
- 3,277 views
- 15 citations
SYSTEMATIC REVIEW
Published on 07 Mar 2022
Sodium Glucose Cotransporter Type 2 Inhibitors Improve Cardiorenal Outcome of Patients With Coronary Artery Disease: A Meta-Analysis
doi 10.3389/fendo.2022.850836
- 3,827 views
- 8 citations
ORIGINAL RESEARCH
Published on 27 Jan 2022
The Urinary Glucose Excretion by Sodium–Glucose Cotransporter 2 Inhibitor in Patients With Different Levels of Renal Function: A Systematic Review and Meta-Analysis
doi 10.3389/fendo.2021.814074
- 4,025 views
- 11 citations
REVIEW
Published on 01 Nov 2021
Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease
doi 10.3389/fendo.2021.749010
- 7,767 views
- 34 citations
SYSTEMATIC REVIEW
Published on 25 Oct 2021
Patients With Type 2 Diabetes Mellitus and Heart Failure Benefit More From Sodium-Glucose Cotransporter 2 Inhibitor: A Systematic Review and Meta-Analysis
doi 10.3389/fendo.2021.664533
- 2,669 views
- 9 citations
Published in
Frontiers in Endocrinology
- Cardiovascular Endocrinology
- Clinical Diabetes
Participating Journals
Frontiers in Neuroscience
Clinical DiabetesOffline
- 3.2 impact factor
- 6.2 citescore
Frontiers in Nutrition
Clinical DiabetesOffline
- 4.0 impact factor
- 5.2 citescore
Frontiers in Public Health
Clinical DiabetesOffline
- 3.0 impact factor
- 4.8 citescore
Impact
- 33kTopic views
- 20kArticle views
- 12kArticle downloads